Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,336 | 19,697 | 20,517 | 22,900 | 18,393 |
| Other current assets | 37 | 0 | 0 | 0 | 0 |
| TOTAL | $17,515 | $19,893 | $20,824 | $23,231 | $18,487 |
| Non-Current Assets | |||||
| PPE Net | 8,945 | 8,935 | 9,085 | 9,174 | 9,238 |
| Intangibles | 346 | 348 | 350 | 352 | 354 |
| Other Non-Current Assets | 4 | 3 | 4 | 4 | 6 |
| TOTAL | $9,294 | $9,286 | $9,439 | $9,530 | $9,598 |
| Total Assets | $26,810 | $29,179 | $30,262 | $32,761 | $28,085 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 24 | 95 | 166 | N/A |
| Accounts payable and accrued liabilities | 320 | 821 | 232 | 681 | 314 |
| Accrued Expenses | 24 | 24 | 24 | 24 | 25 |
| TOTAL | $344 | $870 | $351 | $871 | $339 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $344 | $870 | $351 | $871 | $339 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,534 | 11,525 | 11,515 | 11,505 | 10,677 |
| Common Shares | 12 | 12 | 12 | 12 | 11 |
| Retained earnings | -118,920 | -116,998 | -114,385 | -112,312 | -110,204 |
| Other shareholders' equity | 1 | 1 | 0 | 0 | 0 |
| TOTAL | $26,465 | $28,309 | $29,911 | $31,890 | $27,746 |
| Total Liabilities And Equity | $26,810 | $29,179 | $30,262 | $32,761 | $28,085 |